2016
DOI: 10.1016/j.gie.2015.08.085
|View full text |Cite
|
Sign up to set email alerts
|

EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
130
0
3

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 148 publications
(136 citation statements)
references
References 21 publications
3
130
0
3
Order By: Relevance
“…Moreover, using percutaneous or EUS guidance, a safe mini-invasive approach can be obtained avoiding laparotomy. To the best of our knowledge, 10 patients underwent pancreatic EUS-RFA with the EUSRA electrode without severe adverse events and with high technical success [5,[18][19][20]. The results of our series confirm the feasibility, safety and local thermal effect of the procedure.…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…Moreover, using percutaneous or EUS guidance, a safe mini-invasive approach can be obtained avoiding laparotomy. To the best of our knowledge, 10 patients underwent pancreatic EUS-RFA with the EUSRA electrode without severe adverse events and with high technical success [5,[18][19][20]. The results of our series confirm the feasibility, safety and local thermal effect of the procedure.…”
Section: Discussionsupporting
confidence: 69%
“…The needle temperature is affected by the energy used, which determines the ablation volume reached. In previous studies, 50 W was employed for 10/15 seconds, and the procedure was repeated by reinserting the electrode in different zones until the hyperechoic area sufficiently covered the tumor [5,18]. In this study, a slightly different technical approach was used: the electrode was positioned in the middle of the tumor and a lower radiofrequency power (30 W) was applied.…”
Section: Discussionmentioning
confidence: 99%
“…Another study evaluated the feasibility of EUS-RFA for treatment of symptomatic insulinoma by using a different EUS-RFA needle electrode [48]. Three patients with symptomatic pancreatic insulinoma who refused surgical resection underwent EUS-RFA in an observational human case series.…”
Section: Endoscopic Ultrasound-guided Tumor Ablationmentioning
confidence: 99%
“…It is also possible that in the future endoscopic EUS--controlled ablation of pancreatic NETs, involving the administration of cytotoxic agents or alcohol [181][182][183][184], or using thermoablation [185,186], will become a minimally invasive therapeutic method for patients who cannot be treated surgically (evidence level 4).…”
Section: Endoscopic Treatment Of Pnensmentioning
confidence: 99%